The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The GAIN-C study (BP25438): Randomized phase II trial of RG7160 (GA201) plus FOLFIRI, compared to cetuximab plus FOLFIRI or FOLFIRI alone in second-line KRAS wild type (WT) or mutant metastatic colorectal cancer (mCRC).
Andres Cervantes-Ruiperez
Honoraria - Amgen
Ben Markman
Honoraria - Presentation
Salvatore Siena
No relevant relationships to disclose
Carles Pericay
No relevant relationships to disclose
Giuseppe Aprile
No relevant relationships to disclose
John A. Bridgewater
Consultant or Advisory Role - Merck Serono; Roche; Sanofi
Antonio Cubillo
No relevant relationships to disclose
Ashita Marie Waterston
Other Remuneration - Travel expenses
Rocio Garcia-Carbonero
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - none
Mark Kozloff
Honoraria - Roche/Genentech
Joseph James McKendrick
No relevant relationships to disclose
Leslie M. Samuel
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Other Remuneration - Roche
Jose Alejandro Perez-Fidalgo
No relevant relationships to disclose
Andrew H. Strickland
Research Funding - Amgen; Roche
Katia Bencardino
No relevant relationships to disclose
Irene Moya
No relevant relationships to disclose
Stefania Eufemia Lutrino
No relevant relationships to disclose
Christoph Mancao
Employment or Leadership Position - Roche
Stock Ownership - Roche
Luigi Manenti
Employment or Leadership Position - Roche
Stock Ownership - Roche
Josep Tabernero
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche